RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $55,000 | +5.8% | 46,755 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | -62.3% | 46,343 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $138,000 | +13.1% | 46,226 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $122,000 | -27.4% | 45,984 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $168,000 | -15.6% | 46,351 | +0.9% | 0.00% | -50.0% |
| Q2 2021 | $199,000 | +18.5% | 45,934 | -6.6% | 0.00% | +100.0% |
| Q1 2021 | $168,000 | -1.8% | 49,191 | +0.5% | 0.00% | -50.0% |
| Q4 2020 | $171,000 | +40.2% | 48,943 | -3.8% | 0.00% | +100.0% |
| Q3 2020 | $122,000 | +74.3% | 50,862 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $70,000 | +14.8% | 38,047 | -3.3% | 0.00% | 0.0% |
| Q1 2020 | $61,000 | – | 39,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |